ClinicalTrials.gg
CompletedNCT06868108Updated Nov 4, 2026

Clinical Trial on the Effect of the Flexible Suturing System With Anchors (FSSA) in Full-thickness Rotator Cuff Tendon Tears

An observational study in Rotator Cuff Tears, sponsored by Integrity Orthopaedics, Inc.. Completed at 3 sites in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Integrity Orthopaedics, Inc. (part of Smith & Nephew, Inc.) · Observational

How we know

Updated Nov 4, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 168 studies in Rotator Cuff Injuries with a site in United States — 40 open to participants now, 50 under way, none of them phase 3. Rotator Cuff Injuries · United States.

Enrollment
19th of 38
80 · median 77
Started
2025
with 10 others
Observational
38 of 168
10 open now
Registered
157th of 168
by date

Among the 168 studies in Rotator Cuff Injuries with a site in United States, this one is the 19th largest by enrollment of the 38 observational ones that give a count, is one of 11 that started in 2025, is one of 38 observational ones, and was the 157th registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

40 of the 168 studies in Rotator Cuff Injuries with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Rotator Cuff Injuries with a site in United States, or all of them as a file.
02

Study summary

The purpose of this research study is to evaluate tendon healing when using the Flexible Suturing System with Anchors (FSSA) to surgically repair full-thickness rotator cuff tendon tears.

03

Conditions studied

  • Rotator Cuff Tears

Browse trials for

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

An individual that underwent surgery to repair a torn rotator cuff tear with the Flexible Suturing System with Anchors (FSSA).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Subjects MUST meet ALL the following criteria to be included in the study:

  1. Underwent surgery to repair a torn rotator cuff tear with the Flexible Suturing System with Anchors (FSSA) and is able to obtain a follow-up MRI within 12 months +4 months / -1 month from the surgery date.
  2. Tear size of the supraspinatus (SSP) with or without involvement of the infraspinatus (ISP), confirmed intra-operatively or with the pre-procedural MRI, is greater than or equal to 1 cm.
  3. Between 18 and 70 years old at the time of surgery.
  4. Able to understand the content of the subject information / Form (ICF) and is willing and able to participate in the prospective data collection protocol and comply with the required data collection.

Exclusion criteria

Exclusion Criteria:

Subjects will be excluded from the study if they meet ANY of the following criteria:

  1. Had a prior rotator cuff surgery on the index shoulder.
  2. Has a subscapularis tear with a Lafosse score of 3 or greater, or a teres minor tear requiring repair.
  3. Identified as being repaired in a hybrid approach, where a non-FSSA anchor is used in the case for SSP and/or ISP rotator cuff repair.
  4. SSP and / or ISP tendon ruptures that are considered irreparable or only partially repairable at the time of the intervention.
  5. At any time during the previous 18 months was involved in a workers compensation case or litigation related to bodily injury, whether related or unrelated to the index shoulder.
  6. Has a history of chronic opioid use.
  7. Subjects with condition(s) that contraindicate or complicate outcomes of ARCR such as:

    • Current or prior infection of the ipsilateral shoulder
    • Known inflammatory arthropathy or history of inflammatory arthropathy
    • Chronic joint disease
    • Concomitant labral fixation
    • Concomitant os acromial fixation
    • Glenohumeral joint instability (multiple dislocations/subluxations)
    • Subacromial or intra-articular injection within 3 months prior to surgery
    • Oral or injected use in the following timeframe: 4 weeks prior to surgery through current date
    • Hamada 3 or greater rotator cuff arthropathy on X-ray
    • Goutallier atrophy > Grade 3
    • Proximal humeral fracture or scapular fracture
    • Avascular necrosis of humeral head or glenoid
    • Immunodeficiency disorders
    • Chronic inflammatory disorders
    • Osteoarthritis >2 (Samilson-Prieto)
  8. Has other concurrent medical or other conditions (chronic or acute in nature) that in the opinion of the participating investigator may prevent participation or otherwise render subject ineligible for the study.
  9. Subjects who are unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical .
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (actual)
Patient registry
No

Interventions

  • DeviceFlexible Suturing System with Anchors (FSSA)

    Surgically repaired full-thickness rotator cuff tendon tears with the Flexible Suturing System with Anchors (FSSA).

06

What researchers measure

Primary outcomes

  1. Healing Rate

    The cumulative healing rate of the repaired rotator cuff tendon, confirmed through MRI, studied one year after the intervention and using the Sugaya classification (Sugaya H (2005)), where healing is defined as Sugaya Type I, II, or III.

    Time frame: One year

07

Study locations

3 sites
  • OrthoCarolina Research Institute
    Charlotte, North Carolina 28207, United States
  • Texas Orthopedic Specialist
    Bedford, Texas 76021, United States
  • Houston Methodist The Woodlands
    The Woodlands, Texas 77385, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in May 2026, 14 months.

Of 71 observational studies under Rotator Cuff Injuries, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 165. This study's 14 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Dec 2025 → May 2026 and completion Dec 2025 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2025
First posted
Mar 10, 2025
StartActual
Feb 20, 2025
Primary completionActual
May 11, 2026was Dec 2025
CompletionActual
Jul 14, 2026was Dec 2025
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Nov 4, 2026
Primary completion
Dec 2025→May 11, 2026 (actual)
Nov 4, 2026
Study completion
Dec 2025→Jul 14, 2026 (actual)
Nov 4, 2026
Enrollment
100 (estimated)→80 (actual)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Enrolling by invitation→Completed
    Primary completion Dec 2025→May 11, 2026 (now actual)
    Study completion Dec 2025→Jul 14, 2026 (now actual)
    Enrollment 100 (estimated)→80 (actual)
    + 3 other changes: verification date, oversight details and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06868108
Responsible party
Sponsor
First posted
Mar 10, 2025
Start date
Feb 20, 2025
Primary completion
May 11, 2026
Completion
Jul 14, 2026
Last update
Nov 4, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion